Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayMar 13, 2018 10:00 am

Ballard Power Systems (NASDAQ: BLDP) Starts Presentation at 30th Annual ROTH Conference

Ballard Power Systems (NASDAQ: BLDP) provides clean energy products that reduce customer costs and risks, and helps customers solve difficult technical and business challenges in their fuel cell programs. The company goal is to be the leading global provider of innovative clean energy solutions offering superior performance at a reduced operating cost. For more information, visit the company’s website at www.ballard.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article…

Continue Reading

TuesdayMar 13, 2018 10:00 am

22nd Century (NYSE: XXII) Starts Presentation at 30th Annual ROTH Conference

22nd Century (NYSE: XXII) is a plant biotech company providing technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants and the level of cannabinoids in cannabis plants to be decreased or increased through genetic engineering and plant breeding. The company develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. For more information, visit the company's website at www.xxiicentury.com.…

Continue Reading

TuesdayMar 13, 2018 10:00 am

Flex Pharma, Inc. (NASDAQ: FLKS) Starts Presentation at 30th Annual ROTH Conference

Flex Pharma (NASDAQ: FLKS) is a biotechnology company focused on developing innovative and proprietary treatments for cramps and spasms associated with severe neuromuscular conditions, and exercise associated muscle cramps (EAMCs). The company’s product candidates activate certain receptors in primary sensory neurons, which then act through neuronal circuits to reduce the repetitive firing, or hyperexcitability, of alpha-motor neurons in the spinal cord, thereby preventing or reducing the frequency and intensity of muscle cramps and spasms. For more information, visit the company’s website at www.flex-pharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to…

Continue Reading

TuesdayMar 13, 2018 10:00 am

Implanet SA (IMPZY) Starts Presentation at 30th Annual ROTH Conference

Implanet (OTCQX: IMPZY) provides various spine, knee and arthroscopy orthopedic implants in France, the United States, and internationally. JAZZ™, the company’s flagship product, obtained 510(k) clearance from the FDA in the United States and the CE mark in Europe. The JAZZ™ Band latest generation implant is protected by four sets of global patents and is intended to improve the treatment of spinal disorders requiring spinal fusion surgery. The company’s R&D team focuses on a scientifically and clinically proven implant design, using top quality materials tested to the highest prevailing standards, associated with simple and user-friendly instrumentations. Implanet’s various workgroups, including…

Continue Reading

TuesdayMar 13, 2018 10:00 am

Genfit SA (GNFTF) Starts Presentation at 30th Annual ROTH Conference

Genfit (OTC: GNFTF) is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The company’s therapeutic and diagnostic solutions address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver. Genfit provides diagnostic solutions in various therapeutic areas, such as metabolic diseases, liver diseases, non-alcoholic steato-hepatitis, cholestatic liver diseases, inflammation and autoimmune diseases, and inflammatory bowel diseases. For more information, visit the company’s website at www.genfit.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access…

Continue Reading

TuesdayMar 13, 2018 10:00 am

TechTarget, Inc. (NASDAQ: TTGT) Starts Presentation at 30th Annual ROTH Conference

TechTarget (NASDAQ: TTGT) provides purchase intent-driven marketing and sales services that deliver business impact for enterprise technology companies. Through the creation of abundant, high-quality editorial content across more than 140 highly targeted technology-specific websites, the company attracts and nurtures communities of technology buyers that are researching their companies’ information technology needs. Through understanding the content consumption behavior of these buyers, TechTarget creates the purchase intent insights that drive efficient and effective marketing and sales activities for clients across the globe. For more information, visit the company’s website at www.techtarget.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution…

Continue Reading

TuesdayMar 13, 2018 10:00 am

W&T Offshore, Inc. (NYSE: WTI) Starts Presentation at 30th Annual ROTH Conference

W&T Offshore (NYSE: WTI) is an independent oil and natural gas producer that has operations offshore in the Gulf of Mexico. The company has grown through acquisitions, exploration and development and currently has working interests in approximately 50 producing fields in federal and state waters and has under lease approximately 710,000 gross acres, including about 460,000 gross acres on the Gulf of Mexico Shelf and approximately 250,000 gross acres in the deepwater. Most of the company's daily production comes from wells it operates. For more information, visit the company's website at www.wtoffshore.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution…

Continue Reading

TuesdayMar 13, 2018 10:00 am

Issuer Direct Corp. (NYSE: ISDR) Starts Presentation at 30th Annual ROTH Conference

Issuer Direct (NYSE: ISDR) is a communications and compliance company focusing on the needs of corporate issuers. Issuer Direct’s principal platform, Platform id., empowers users by eliminating the complexity associated with producing and distributing financial and business communications through thoughtfully integrating the most relevant tools, technologies, and services. Headquartered in Research Triangle Park, NC, Issuer Direct serves more than 2,000 public and private companies in more than 18 countries. For more information, visit the company’s website at www.issuerdirect.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services…

Continue Reading

TuesdayMar 13, 2018 10:00 am

iAnthus Capital Holdings, Inc. (OTC: ITHUF) (CSE: IAN) Starts Presentation at 30th Annual ROTH Conference

iAnthus Capital Holdings (OTCQB: ITHUF) owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to licensed cannabis cultivators, processors and dispensaries throughout the United States. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and healthcare services, iAnthus provides a combination of capital and hands-on operating and management expertise. The company harnesses these skills to support operations across six states. For more information, visit the company’s website at www.iAnthuscapital.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to…

Continue Reading

MondayMar 12, 2018 8:30 pm

Hemispherx Biopharma, Inc. (NYSE: HEB) Starts Presentation at 30th Annual ROTH Conference

Hemispherx Biopharma (NYSE: HEB) is an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx's flagship products include Alferon N Injection® and the experimental therapeutic rintatolimod. Rintatolimod is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Hemispherx's platform technology includes components for potential treatment of various severely debilitating and life-threatening diseases. For more information, visit the company’s website at www.hemispherx.net. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000